Navidea Biopharmaceutical (AMEX:NAVB) reported its Q4 earnings results on Wednesday, March 23, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Navidea Biopharmaceutical missed estimated earnings by 300.0%, reporting an EPS of $-0.12 versus an estimate of $-0.03.
Revenue was down $168.90 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 0.69% drop in the share price the next day.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
